Neurotrophin-3 is increased in skin in human diabetic neuropathy

Journal of Neurology Neurosurgery and Psychiatry

Volumn 65, Issue 3, 1998, Pages 393-395

  Kennedy, A J ^a   Wellmer, A ^a   Facer, P ^a   Saldanha, G ^a   Kopelman, P ^a   Lindsay, R M ^b   Anand, P ^a,c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b REGENERON PHARMACEUTICALS INC   (United States)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Diabetic neuropathy; Human skin; Neurotrophin 3

Indexed keywords

NEUROTROPHIN 3;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENERVATION; DIABETES MELLITUS; DIABETIC NEUROPATHY; EPIDERMIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; KERATINOCYTE; NERVE CONDUCTION; NERVE FIBER; PRIORITY JOURNAL; SKIN BIOPSY;

EID: 0031679209     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.65.3.393     Document Type: Article

References (18)

1. Lindsay RM. Role of neurotrophins and trk receptors in the development and maintenance of sensory neurons: an overview. Philos Trans R Soc Lond B Biol Sci 1996;351:365-73.
2. Anand P, Terenghi G, Warner G, et al. The role of endogenous nerve growth factor in human diabetic neuropathy. Nat Med 1996;2:703-7.
3. Tessarollo L, Vogel KS, Palko ME, et al. Targeted mutation of the neurotrophin-3 gene results in loss of muscle sensory neurons. Proc Natl Acad Sci USA 1994;91:11844-8.
4. Ernfors P, Kucera J, Lee KF, et al. Studies on the physiological role of brain-derived neurotrophic factor and neurotrophin-3 in knockout mice. Int J Dev Biol 1995;39: 799-80.
5. Zhou XF, Rush RA. Peripheral projections of rat primary sensory neurons immunoreactive for neurotrophin 3. J Comp Neurol 1995;363:69-77.
6. Airaksinen MS, Koltzenburg M, Lewin GR, et al. Specific subtypes of cutaneous mechanoreceptors require neurotrophin-3 following peripheral target innervation. Neuron 1996;16:287-95.
7. Albers KM, Perrone TN, Goodness TP, et al. Cutaneous overexpression of NT-3 increases sensory and sympathetic neuron number and enhances touch dome and hair follicle innervation. J Cell Biol 1996;134:487-97.
8. Fundin BT, Silos-Santiago I, Ernfors P, et al. Differential dependency of cutaneous mechanoreceptors on neurotrophins, trk receptors, and P75 LNGFR. Dev Biol 1997;190:94-116.
9. Helgren ME, differ KD, Torrento K, et al. Neurotrophin-3 administration attenuates deficits of pyridoxine-induced large-fiber sensory neuropathy. J Neurosci 1997;17:372-82.
10. Apfel S, Adornato B, Dyck PJ, et al. Results of a double-blind, placebo-controlled trial of a recombinant human nerve growth factor in diabetic polyneuropathy. Ann Neurol 1996;40:954.
11. Wellmer A, Sharief MK, Kopelman PG, et al. A clinical trial of recombinant human brain-derived neruotrophic factor (rhBDNF) in diabetic neuropathy [abstract]. J Neurol Neurosurg Psychiatry (in press).
12. Dyck PJ. Quantitating severity of neuropathy. In: Dyck PJ, Thomas PK, eds. Peripheral neuropathy. 3rd ed. Philadelphia: Saunders, 1993:686-97.
13. Shu S, Ju G, Fan L. The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci Lett 1988;85:169-71.
14. Rodriguez-Pena A, Botana M, Gonzalez M, et al. Expression of neurotrophins and their receptors in sciatic nerve of experimentally diabetic rats. Neurosci Lett 1995;200:37-40.
15. Terenghi G, Mann D, Kopelman PG, et al. TrkA and trkC expression is increased in human diabetic skin. Neurosci Lett 1997;228:33-6.
16. Klein R, Silos-Santiago I, Smeyne RJ, et al. Disruption of the neurotrophin-3 receptor gene trkC eliminates Ia muscle afferents and results in abnormal movements. Nature 1994;368:249-51.
17. Ihara C, Shimatsu A, Mizuta H, et al. Decreased neurotrophin-3 expression in skeletal muscles of streptozotocin-induced diabetic rats. Neuropeptides 1996; 30:309-12.
18. Fernyhough P, Maeda K, Tomlinson DR. Brain-derived neurotrophic factor messenger RNA levels are up-regulated in hindlimb skeletal muscle of diabetic rats - effect of denervation. Exp Neurol 1996;141:297-303.